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TheaimofthestudywastoassesschosenfactorsofgeneticsusceptibilitytoDMT1:DRB1,DQB1,andTNF-αpolymorphisms-308
(G/A) in children with DMT1 and their up-to-now healthy siblings. Then we tested whether the association between TNF-α genes
andDMT1isindependentofHLA.87diabeticchildren,their78siblings,and85personsfromhealthycontrolgroupwerefollowed
up. The highest risk of DMT1 was connected with alleles: DRB1∗0401 (OR = 3.39; CI: 1.55–7.41), DRB1∗0301 (OR = 2.72; CI:
1.48–5.01), DQB1∗0201 (OR = 4.04; CI: 2.17–7.52), DQB1∗0302 (OR = 5.08; CI: 2.54–10.14), and TNF-α-308 A allele (OR =
2.59; CI: 1.23–5.44). Moreover linkage disequilibrium for TNF-α-308 A allele with DRB1∗0301 and DQB1∗0201 was observed in
both diabetic children and their siblings. Diabetic children and their siblings present similar genetic risk factors for DMT1. The
association between TNF-α-308 A allele and DMT1 is dependent of HLA-DRB1 and DQB1 alleles.
Copyright © 2006 Gra˙ zyna Deja et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Diabetes mellitus type 1 (DMT1) is believed to result from
selective elimination of pancreatic β cells caused by progres-
sive inﬂammatory autoimmune reaction. It is currently ac-
cepted that genetic susceptibility interacting with unknown
environmental factors is responsible for the autoimmune ba-
sis of DMT1 [1, 2]. Both genome screens and studies search-
ing candidate genes have conﬁrmed that DMT1 is a het-
erogeneous polygenic disorder, with about 20 of loci con-
tributing to the susceptibility to disease [3–5]. It is believed
that the most important genes, responsible for above 50%
genetic risk of developing diabetes, are located in HLA re-
gion on chromosome 6p21 [6]. The ﬁrst region of HLA con-
nected with susceptibility to DMT1 (HLA class I B8 and
B15) was found thirty years ago [7]. The positive associa-
tion of certain HLA class II alleles with DMT1—DQ8/DR4
and DQ2/DR3 in most Caucasian populations has been very
well documented [1, 6, 8]. The tumor necrosis factor α
(TNF-α) is known as proinﬂammatory cytokine implicated
in the pathogenesis of autoimmune and infectious diseases.
The genes of TNF-α are located in the region HLA class III
(250kb centromeric of the HLA-B and 850kb telomeric of
the class II HLA-DR genes in humans) [9, 10]. Although
contribution of TNF-α to DMT1 is not well established in
humans in multicenter studies, it has been shown in an ani-
mal model that TNF-α can be cytotoxic for β-cells supported
by both interleukin-1 and interferon-γ [11, 12]. NOD mice
that overexpress TNF-α in their β-cells are predisposed to
diabetes [13]. Moreover it has been reported, that levels of
circulating monocyte and T-cell type 1 proinﬂammatory cy-
tokines are elevated in patients at the onset of diabetes [14].
It has been pointed in several studies [9, 10, 15–17], that
TNF-α region contains a few polymorphisms (single nu-
cleotide polymorphisms—SNP) which could be connected
with a diﬀerent cytokine secretion. Probably diﬀerent places
in the promotor region, in the ﬁrst intron, in the 3’untrans-
lated regions and microsatellites could determine diﬀerent
levels of TNF-α production [18–21]. The TNF-α promotor
polymorphism-308 in the human involving the substitution
of guanine (knownas TNF1) by adenosine (known as TNF2)
has been most often used in the associated studies. TNF2 al-
lele seems to have a real functional signiﬁcance because it is a
muchstrongertranscriptionalactivatorthanthecommonal-
leleTNF1[9].Inviewofgenelocation,ithasbeenspeculated
that polymorphism of this locus might contribute to HLA
association with DMT1. Previous studies in west European
populations [22, 23] have indicated a strong association of2 Mediators of Inﬂammation
TNF2 allele with DMT1, however the authors of these papers
suggestthattheseassociationsmayoriginate fromthetypical
for HLA linkage disequilibria (LD) between estimated alle-
les in the TNF locus and other alleles of HLA region. How-
ever studies concerning middle-east European populations
are few and contradictory. It was shown in a Latvian study
[24] that the microsatellites A5 and TNF2 are both indepen-
dently associated with the disease.
Theaimofthisstudyisanassessmentofchosenfactorsof
genetic susceptibility to DMT1 such as HLA-DRB1, DQB1,
and TNF-α polymorphism-308 (G/A) in children with di-
abetes and their up to now healthy siblings. Moreover we
would like to estimate whether possible relationship of TNF-
α-308 (G/A) is due to a primary association or mediated by
LD with the susceptible DRB1 and DQB1 alleles.
MATERIAL AND METHODS
Subjects
A group of 87 diabetic children (52 boys and 35 girls) in me-
dian age of 10.19 years (quartile 7.52–12.56, age range 1.55–
18.2) were randomly selected as the subject of this study. All
patients were hospitalized in Department of Endocrinology
and Diabetology in Katowice with a new onset of diabetes.
The diagnosis of DMT1 was made according to WHO and
ISPAD criteria [25]. An inclusion criterion for enrolment
to the study was presence of at least one disease-associated
autoantibody (GADA-65, IAA, or IA2A). The second group
studied was a group of 78 of their related brother and/or sis-
ter (40 boys and 38 girls) in median age of 10.82 years (quar-
tile7.08–14.18,agerange0.69–19.99)withoutanysymptoms
of impaired glucose tolerance and normal fasting glucose
level. Blood samples for genetic tests were taken once, both
from diabetic children and their siblings with no diagnostic
signs of diabetes. As the healthy control group, 85 subjects
(44 men and 41 women, aged 18–35 years) without diabetes
or any other autoimmune disease in family were enrolled.
BLOOD TESTS
Immunologicaltest
Samples for disease-associated autoantibodies: glutamic acid
decarboxylase antibodies (GADA-65), tyrosine phosphatase
antibodies (IA2A) and insulin antibodies (IAA) were ob-
tained from children with DMT1 before initiation of insulin
treatment. Concentrations of autoantibodies were measured
by radioimmune assay (RIA—CIS Bio International) in the
DepartmentofIsotope Diagnostics ofthe MedicalUniversity
of Silesia in Katowice according to the protocol described in
instructionsofkits.IntheGADAandIA2Aassaytests,serum
samples were ﬁrst incubated with 125I-labelled human GAD
or human recombinant IA2, respectively. This was followed
byadditionofsolidphaseproteinAtoprecipitatethelabelled
GAD-GAD antibodies or IA2-IA2 antibodies complexes. Af-
ter centrifugation, the precipitate was counted for 125Ia n d
the amount of radioactivity in the precipitate was propor-
tional to the concentration of GADA or IA2A in the test
sample. The presence of circulating IAA was estimated on a
semiquantitative basis, by the determination of the binding
of 125I-Tyr-A 14 insulin to the serum fraction precipitated by
the polyethylene glycol. After incubation and centrifugation
radioactivity of supernatant was measured by counting in
a gamma scintillation counter. All the tests were performed
in duplicate. The measurements ranges were as follows: for
IA2A 0–50U/mL, for GADA 0–300U/mL, and for IAA 0–
100%. The results for GADA and IA2A above 0.75U/mL and
for IAA above 7% were taken as positive.
HLAtests
The genetic assays were performed in The Regional Blood
Centre in Katowice. HLA class II alleles were typed using
PCR-SSP method. Allele speciﬁc tests One Lambda (CYT-
GEN, USA) were used for HLA-DRB1∗ and DQB1∗ typing.
Peripheral blood samples (EDTA) were the source of the ge-
nomic DNA. DNA was isolated by salting out method using
3–5mL 6 M NaCl [26]. First leucocytes were resuspended
in 5mL SE buﬀer with adding 250ul 20% SDS and 15μL
Proteinase (10mg/μL). Incubation was carried out for 17
h o u r sa t3 7 ◦C. Next DNA extraction was performed using
12.5mL absolute alcohol and DNA samples were stored at
room temperature (30 min) to dry. The PCR mixture con-
sisted of D-mix ready for use, Taq Polymerase (5U/μL), and
DNA (100ng/μL). The PCR program was performedaccord-
ing to the protocol: 1 cycle: 96◦C (130sec) and 63◦C (60sec),
next 9 cycles: 96◦C (10sec) and 63◦C( 6 0s e c ) ,a n dﬁ n a l l y2 0
cycles: 96◦C (10sec), 59◦C (50sec), 72◦C (30sec). After gel
electrophoresis of PCR products, UV transilluminator was
used for visualization and completing an ampliﬁcation pat-
tern.
TNF-αpolymorphism-308(G/A)tests
The polymorphism in the promoter region of TNF-α poly-
morphism-308(G/A)wasidentiﬁedusingPCR-SSPmethod.
Commercial One Lambda (CYTGEN, USA) kit was used
[27]. DNA from human leucocytes was prepared by salting
out method using 6 M NaCl [26]. DNA samples before PCR
were resuspended in 10mM Tris HLC, ph 8.0–9.0 at a con-
centration100ng/ul.ThePCRreagentswereasfollows:DNA
sample (19ul), D-Mixture ready for use (180ul), and Taq
Polymerase (concentration 5U/ul −1ul). PCR cycling con-
ditions were: 1 cycle 96◦C (130sec), and 63◦C (60sec), next
9 cycles: 96◦C( 1 0s e c )a n d6 3 ◦C (60sec) and 20 cycles: 96◦C
(10sec), 59◦C( 5 0s e c ) ,a n d7 2 ◦C (30sec). Finally PCR prod-
uctswereseparatedonagarosegelcontainingTBEbuﬀerand
visualized by UV transilluminator.
STATISTICAL ANALYSIS
The frequency of HLA alleles and polymorphism of TNF-α
308(G/A)wereestimatedineachgroupwithanexpectation-
maximization (EM) algorithm, as implemented in Arlequin
2.000 program [28]. The linkage disequilibrium betweenGra˙ zyna Deja et al 3
alleles of estimated loci was determined by D statistic:
D = pab − pa · pb for two compared alleles loci 1 and 2,
(1)
where pa means frequency of allele a on the ﬁrst estimated
locus, pb meansfrequencyofalleleb onthesecondestimated
locus, pab means frequency of pair ab.
To assess the risk associated with genetic factors the odds
ratio (OR) with 95% conﬁdence interval (CI) was calculated
for all alleles and haplotypes according to the Woolf’s for-
mula. The ﬁnal veriﬁcation of risk factors for DMT1 was car-
riedoutaftercreatingmultiplelogisticregressionmodel.The
model was built in stages. First univariate analysis was used
to identify all discrete variables predictive for onset of dia-
betes. For each of them logistic regression equation was per-
formed. Using algorithm step forward, the best classiﬁcation
model was searched. The variable of the highest predictive
power was chosen as the ﬁrst one. The remaining variables
were added in the next step. The searching process was ﬁn-
ished when none of the remaining variables signiﬁcantly im-
proved classiﬁcation properties of the model. χ2 statistic and
qualiﬁcation criterion Cp were applied for models’ compari-
son.
RESULTS
Genetic typing of HLA-DRB1 and DQB1 on the low resolu-
tion level in diabetic children revealed predominance of the
following alleles: DRB1∗04 (33.33%), DRB1∗03 (31.03%),
DQB1∗02 (39.65%), and DQB1∗03 (37.93%). The haplo-
types recognized as predisposing to the disease: DRB1∗04
DQB1∗03 (65.5%, 57 children) and/or DRB1∗03 DQB1∗02
(62%, 54 children) were found in the most ill children (91%,
79 children). There were no signiﬁcant diﬀerences in the fre-
quency of haplotype in relation to sex or age at the onset.
Genetic typing of HLA-DRB1 and DQB1 on the low resolu-
tion level in siblings of diabetic children revealed predomi-
nance of the following alleles: DRB1∗03 (23.72%), DRB1∗04
(23.08%), DQB1∗02 (30.77%), and DQB1∗03 (33.33%).
Similarly to ill siblings predominance of following haplo-
types was observed: DRB1∗03 DQB1∗02 (47.4%, 37 chil-
dren) and DRB1∗04 DQB1∗03 (44.8%, 35 children).
The comparative analysis of the distribution of DRB1
and DQB1 alleles was performed on the basis of families
with pairs: ill child-healthy child. Diabetic children with-
out siblings were excluded from this part of analysis. In the
families with some healthy children, one of them was ran-
domly selected. Finally the 44 pairs of children were com-
pared with the 85 healthy subjects from the control group.
The distribution of estimated alleles DRB1 and DQB1 in all
groups is shown in Tables 1 and 2. Global test while com-
paring all groups showed that both diabetic children and
their siblings signiﬁcantly diﬀered from the healthy control
group (P<. 001), with no diﬀerence between examined
pairs (P = .1039). Alleles associated with the highest risk of
DMT1 in the examined population within the DRB1 genes
were as follows: 0401 (OR = 3.39; 1.55–7.41) and 0301 (OR
= 2,72; 1.48–5.01), whereas within DQB1 genes: 0302 (OR
= 5.08; 2.54–10.14) and 0201 (OR = 4.04; 2.17–7.52). The
risk wassigniﬁcantly increased whenallelescoexisted in both
loci. The risk calculated for given haplotypes was as fol-
lows:DRB1∗0401DQB1∗0302(OR=10.67;3.49–32.67)and
DRB1∗0301 DQB1∗0201 (OR = 4.73; 2.4–9.34). Moreover,
thestrongprotectionagainstdiabeteswasassociatedwiththe
allele of DRB1∗1501 (OR = 0.06; 0.01–0.44) and to a lesser
extent with the allele of DQB1∗0301 (OR = 0.1; 0.02–0.46).
GeneticvariabilityofTNF-α-308wasanalyzedin44pairs
of diabetic child-sibling and 36 subjects randomly selected
from the control group. The purpose of this analysis was to
answer the question whether this polymorphism may be a
risk factor for DMT1. The study revealed signiﬁcant diﬀer-
ences only between diabetic children and the healthy control
group (P = .013). The presence of the allele TNF2 is associ-
ated with increased risk of DMT1 (36.36% versus 18.1%; OR
=2.59;1.23−5.44).ThedistributionofTNF-α-308polymor-
phisms in all groups is shown in Table 3.
The analysis of genetic samples conﬁrms linkage disequi-
librium (LD) for alleles DRB1 and DQB1 associated with
predisposition to DMT1 in all groups, previously reported
in literature [1, 6, 8]. For diabetic children value of D was as
follows: for alleles DRB1∗0401 and DQB1∗0302 (D = 0.14;
χ2 = 46.04; P<. 001) and for alleles DRB1∗0301 and
DQB1∗0201 (D = 0.21; χ2 = 72.09; P<. 001). Moreover
LD was noted for the TNF-α- 3 0 8Aa l l e l ew i t hD R B 1 ∗0301
allele (D = 0.13; χ2 = 29.16; P<. 001) and DQB1∗0201
allele (D = 0.12; χ2 = 2.95; P<. 001) in diabetic chil-
dren. The similar LD was observed in siblings for TNF2 with
DRB1∗0301 (D = 0.13; χ2 = 49.76; P<. 001) and for TNF2
with DQB1∗0201 (D = 0.11; χ2 = 26.91; P<. 001).
The ﬁnal assessment of genetic susceptibility to DMT1
in the examined group of diabetic children was based on
the multiple logistic regression model. Firstly all the dis-
crete variables predictive for onset of diabetes in the
univariate analysis were taken into account as follows:
the DRB1∗04, DRB1∗0301, DQB1∗0302, DQB1∗0201,
DRB1∗04 DBB1∗0302, DRB1∗0301 DQB1∗0201, and the
TNF2. Finallythefollowingvariablesremainedinthemodel:
DRB1∗04, DQB1∗0302, and DRB1∗0301 DQB1∗0201. The
presence of these alleles and haplotype determines correct
classiﬁcation of diabetic children in 90.1%. Allele TNF2
did not correct signiﬁcantly classiﬁcation properties of the
model. The model is described in Table 4. The predictive
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lation (exactly in the Upper Silesia population). Like in most
Caucasian populations studied so far [1, 6, 8, 29], haplo-
types: DRB1∗04 DQB1∗0302 and DRB1∗0301 DQB1∗0201
showed the highest association with onset of DMT1 also in4 Mediators of Inﬂammation
Table 1: Estimated DRB1 alleles’ frequencies in diabetic children, siblings, and healthy control group. P<. 001: diabetic children versus
healthy control group. P<. 001: siblings versus healthy control group. P = NS: diabetic children versus siblings.
Allele DRB1 Diabetic children n = 44 Siblings n = 44 Healthy control group n = 85
Frequency (%) SD Frequency (%) SD Frequency (%) SD
0101 5.68 2.48 9.09 3.08 8.82 2.18
0102 3.41 1.95 2.27 1.60 1.18 0.83
0301 32.95 5.04 22.73 4.49 15.29 2.77
0304 1.14 1.14 0.00 0.00 0.00 0.00
0401 20.45 4.33 14.77 3.80 7.06 1.97
0402 4.55 2.23 3.41 1.95 1.18 0.83
0404 3.41 1.95 3.41 1.95 0.59 0.59
0405 1.14 1.14 1.14 1.14 0.00 0.00
0408 1.14 1.14 1.14 1.14 0.00 0.00
0419 1.14 1.14 1.14 1.14 0.00 0.00
0701 9.09 3.08 9.09 3.08 13.53 2.63
0801 2.27 1.60 2.27 1.60 2.35 1.17
0901 1.14 1.14 0.00 0.00 2.94 1.30
1001 0.00 0.00 0.00 0.00 0.59 0.59
1101 1.14 1.14 2.27 1.60 5.29 1.72
1103 0.00 0.00 2.27 1.60 3.53 1.42
1123 0.00 0.00 2.27 1.60 0.00 0.00
1201 0.00 0.00 1.14 1.14 4.71 1.63
1301 0.00 0.00 2.27 1.60 7.06 1.97
1302 1.14 1.14 3.41 1.95 3.53 1.42
1303 0.00 0.00 1.14 1.14 0.00 0.00
1306 0.00 0.00 1.14 1.14 0.00 0.00
1401 1.14 1.14 0.00 0.00 4.12 1.53
1501 1.14 1.14 4.55 2.23 16.48 2.85
1502 0.00 0.00 1.14 1.14 0.00 0.00
1509 1.14 1.14 2.27 1.60 0.00 0.00
1601 6.82 2.70 5.68 2.48 0.59 0.59
1602 0.00 0.00 0.00 0.00 1.18 0.83
thisstudy.Comparingourdatawithotherstudiesperformed
in Poland [30, 31], some similarities and diﬀerences could be
observed. Generally, distributions of DRB1 alleles and hap-
lotypes connected with DMT1 in diﬀerent subpopulations
of our country are rather similar—the same haplotypes de-
termine predisposition to and protection from the disease.
However the frequencies of DQB1 alleles and associations
with DMT1 diﬀer in examined Polish subpopulations. In
children from the central region of Poland [30]o n l ya l l e l e
DQB1∗0302 determined high risk of DMT1 (OR = 5.59; CI:
3.26–9.58), that corresponds with the risk in our population
(OR = 5.08; CI: 2.54–10.14) and the risk in the north-eastern
region of Poland (RR = 19.8) [31]. The positive connection
with DMT1 of DQB1∗0201 was not observed in children
from the central region of Poland, while it was conﬁrmed
in the north-western subpopulation of Poland (RR = 6.25)
and in our study (OR = 4.04; CI: 2.17–7.52). At the other
hand the highest protective eﬀect of DQB1∗0602 was not
observed in our study as opposite to the study mentioned
above. It was probably due to quite diﬀerent distribution of
this allele in the healthy control populations (the frequency
of DQB1∗0602 in the Silesian population is 8.2% versus
34.2% in the north-western subpopulation of Poland). Such
big diversiﬁcation of estimated alleles in the diﬀerent regions
of Poland is probably the result of historical and economi-
cal aspects, for example migration of Polish population be-
cause of borders changing and to the most urbanized region
of Poland (Upper Silesia region).
PreviousstudiesinEuropeanpopulations [23]andinthe
USA [32] indicated strong association between TNF-α-308
A allele (TNF2) and DMT1. In one of the ﬁrst studies [23]a
signiﬁcantdiﬀerenceinallelefrequencybetweenpatientsand
control group was observed (P = .03), but also very strong
association of the uncommon TNF2 allele with the HLA-B8
and HLA-DR3 was noted. The relative risk of DMT1 (RR)
in this study was calculated for HLA genes as follows: 3.1 forGra˙ zyna Deja et al 5
Table 2: Estimated DQB1 alleles’ frequencies in diabetic children, siblings, and healthy control group. P<. 001: diabetic children versus
healthy control group. P<. 001: siblings versus healthy control group. P = NS: diabetic children versus siblings.
Allele DQB1 Diabetic children n = 44 Siblings n = 44 Healthy control group n = 85
Frequency (%) SD Frequency (%) SD Frequency (%) SD
0201 37.50 5.19 28.41 4.84 12.94 2.58
0202 5.68 2.48 3.41 1.95 13.53 2.63
0301 2.27 1.59 10.23 3.25 18.82 3.01
0302 32.96 5.04 25.00 4.64 8.82 2.18
0303 0.00 0.00 0.00 0.00 4.71 1.63
0304 1.14 1.14 1.14 1.14 0.00 0.00
0402 0.00 0.00 0.00 0.00 0.59 0.59
0403 0.00 0.00 0.00 0.00 0.59 0.59
0501 12.50 3.55 14.77 3.80 8.24 2.12
0502 4.55 2.23 3.41 1.95 7.06 1.97
0503 0.00 0.00 0.00 0.00 3.53 1.42
0504 0.00 0.00 0.00 0.00 0.59 0.59
0601 0.00 0.00 3.41 1.95 4.71 1.63
0602 0.00 0.00 4.55 2.23 8.24 2.12
0603 2.27 1.59 2.27 1.60 4.71 1.63
0604 1.14 1.14 3.41 1.95 1.18 0.83
0609 0.00 0.00 0.00 0.00 0.59 0.59
0611 0.00 0.00 0.00 0.00 0.59 0.59
0619 0.00 0.00 0.00 0.00 0.59 0.59
Table 3:EstimatedTNF-α-308alleles’frequenciesindiabeticchildren,siblings,andhealthycontrolgroup.P = .013:diabeticchildrenversus
healthy control group. P = NS: siblings versus healthy control group. P = NS: diabetic children versus siblings.
Allele TNF-α Diabetic children n = 44 Siblings n = 44 Healthy control group n = 36
Frequency (%) SD Frequency (%) SD Frequency (%) SD
G 0.64 0.05 0.71 0.05 0.81 0.04
A 0.36 0.05 0.28 0.04 0.18 0.04
DR3 and 2.2 for TNF2. The connection between TNF2 and
DMT1 was conﬁrmed in other studies; moreover studies of
diﬀerent populations showed the diversiﬁcation of distribu-
tion of TNF2 in general population. The frequency of TNF2
in Caucasian populations is estimated to be about 17–22%
[22,23],whileinAsiancountriesitisfoundveryrarely1–3%
[32]. It was also described in Moroccan population [33] that
the presence of allele A on both chromosomes could bring
surprising eﬀect. Independent of LD with HLA class II, TNF
haplotype-308 TNFA∗2 + 252 TNFB∗2 showed a signiﬁcant
protective eﬀect (OR = 0.031) against the disease. Authors of
thispaperexplainedthatthisresultcouldbedetectedbecause
Morocco shows the highest frequency of the TNF2 allele yet
reported (genotypes: 25.9% for the TNF∗1,2 and 19.8% for
TNF∗2,2 in the general population).
In this study allele TNF2 responsible for the highest se-
cretion was observed in 36.4% children with DMT1, while
in control group it was found rarely—in 18.1% (P = .013).
Therefore allele TNF2 could be recognized as a risk factor
for DMT1 (OR = 2.59; 1.23–5.44). But this result should be
interpreted with caution because of LD between TNF-α al-
leles and HLA alleles: DRB1 and DQB1. In a comparable
analysis LD between TNF2 and alleles DRB1∗0301 and also
DQB1∗0201 both in diabetic children and siblings were rec-
ognized. These results are yet another conﬁrmation of results
ofthestudiesperformedinotherCaucasianpopulationsthat
connectionofTNF-αwithDMT1isdependentofHLAgenes
[22, 23, 32]. Obtained results are also the next proof for
real genetic similarity of siblings. The signiﬁcant diﬀerences
in distribution of TNF2 were observed only when compar-
ing diabetic children with control group; however there were
no diﬀerences between diabetic children and siblings. It was
shown in another study [34] that in healthy family mem-
bers of children with DMT1 overproduction of proinﬂam-
matory cytokines existed. Because of the fact that many ge-
netic factors and immunoregulatory abnormalities involved6 Mediators of Inﬂammation
Table 4: Parameters of logistic regression model.
Parameter estimate P value OR (95% CI)
Intercept −2.29 P = .0002 —
DRB1∗04 1.93 P = .0256 6.94 (1.23–39.12)
DQB1∗0302 1.80 P = .0308 6.05 (1.1–31.86)
DRB1∗0301 DQB1∗0201 4.10 P<. 0001 60.12 (8.75–412.9)
in dibetogenesis are shared by healthy siblings, further stud-
ies should be performed to determine what factors are re-
quired to make the disease on this background.
CONCLUSION
Diabetic children and their healthy siblings present similar
genetic risk factors for DMT1: allele DRB1, DQB1 and poly-
morphisms of TNF-α-308 (G/A). The association between
TNF2 and DMT1 is dependent of HLA-DRB1 and DQB1 al-
leles.
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